miniMarrow Company
miniMarrow presents a new disruptive therapeutic approach for the in-situ production of blood components in leukemic patients to replace weekly and burdensome transfusions markedly increasing patient quality-of-life.
miniMarrow is operating in stealth mode.
miniMarrow was established in Renens, Vaud
Headquarters:
Renens, Vaud, Switzerland, Europe
Founded Date:
2020-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Investors:
MassChallenge Switzerland
Ipo Status:
private
City:
Renens
Region:
Vaud
Country:
Switzerland